Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PRNewsWire • 11/01/24
Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business HighlightsPRNewsWire • 11/01/24
Akebia Therapeutics Signs Commercial Supply Contract with Leading Dialysis Organization to Enable Access to Vafseo® (vadadustat) for Patients on DialysisPRNewsWire • 10/22/24
Akebia Therapeutics Announces Seven Poster Presentations at ASN Kidney Week 2024PRNewsWire • 10/15/24
CMS Grants TDAPA Reimbursement for Vafseo® (vadadustat) beginning January 1, 2025PRNewsWire • 10/10/24
Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply Contract to Enable Access to Vafseo® (vadadustat) for Patients on DialysisPRNewsWire • 10/07/24
Akebia Therapeutics and U.S. Renal Care Initiate the VOICE Trial of Vafseo® (vadadustat) for Patients on DialysisPRNewsWire • 09/05/24
Akebia Therapeutics (AKBA) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/08/24
Akebia Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business HighlightsPRNewsWire • 08/08/24
Akebia Therapeutics to Report Second Quarter 2024 Financial Results and Discuss Recent Business HighlightsPRNewsWire • 08/02/24
Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo® (vadadustat) TabletsPRNewsWire • 07/11/24
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual ConferencePRNewsWire • 06/27/24
Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business OfficerPRNewsWire • 06/24/24
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor ConferencePRNewsWire • 05/14/24
Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/09/24
Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsPRNewsWire • 05/09/24
Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business HighlightsPRNewsWire • 05/02/24
Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia ManagementSeeking Alpha • 04/04/24